JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312729200 on March 16, 2004

J. Biol. Chem., Vol. 279, Issue 21, 22267-22275, May 21, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/21/22267    most recent
M312729200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmqvist, K.
Right arrow Articles by Welsh, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmqvist, K.
Right arrow Articles by Welsh, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Adaptor Protein Shb Binds to Tyrosine 1175 in Vascular Endothelial Growth Factor (VEGF) Receptor-2 and Regulates VEGF-dependent Cellular Migration*

Kristina Holmqvist{ddagger}, Michael. J. Cross§, Charlotte Rolny{ddagger}, Robert Hägerkvist{ddagger}, Nader Rahimi||, Taro Matsumoto**, Lena Claesson-Welsh§, and Michael Welsh{ddagger}{ddagger}{ddagger}

From the {ddagger}Department of Medical Cell Biology, Uppsala University, Uppsala 75123, Sweden and the §Department of Genetics and Pathology, Uppsala University, Uppsala 75185, Sweden, and ||Department of Ophthalmology, School of Medicine, Boston University, Boston, Massachusetts 02118, and the **Division of Cell Regeneration and Transplantation, Nihon University School of Medicine, Tokyo 173-8610, Japan

Previous studies have shown that the adaptor protein Shb is involved in receptor tyrosine kinase signaling. In this study, we demonstrate that Shb is phosphorylated in an Src-dependent manner upon vascular endothelial growth factor (VEGF) stimulation using porcine aortic endothelial cells expressing the human VEGF receptor 2 (VEGFR-2) (KDR). In co-immunoprecipitation experiments, we could detect an interaction between Shb and the VEGFR-2 in human telomerase-immortalized microvascular endothelial cells. Furthermore, in a glutathione S-transferase pull-down assay, the Src homology 2 domain of Shb was shown to interact with phosphorylated tyrosine 1175 in the C-terminal tail of VEGFR-2. VEGF-induced Shb phosphorylation was lost in porcine aortic endothelial cells expressing a chimeric murine VEGFR-2 (Flk-1) with a mutation at the corresponding position. Shb expression was specifically decreased by 80%, in a transient manner, by using the short interfering RNA technique. Reduced Shb expression led to a loss of stimulation of phosphatidylinositol 3-kinase, phosphorylation of focal adhesion kinase at tyrosine 576, the generation of focal adhesions, and stress fiber formation in response to VEGF. Furthermore, we show that VEGF-induced migration is inhibited in Shb short interfering RNA-treated cells. Our data demonstrate that Shb is important for VEGF signaling in endothelial cells. This is achieved by Shb binding to tyrosine 1175 in the VEGFR-2, which regulates VEGF-induced formation of focal adhesions and cell migration, of which the latter occurs in a phosphatidylinositol 3-kinase-dependent manner.


Received for publication, November 20, 2003 , and in revised form, March 10, 2004.

* This work was supported by grants from the Juvenile Diabetes Foundation International, the JDRF-SRC-SDA joint program on stem cell research, the Swedish Medical Research Council Grant 31X-10822, the Swedish Diabetes Association, the Novo-Nordisk Foundation, the Family Ernfors Fund, and the Association for International Cancer Research (to M. J. C. and L. C.-W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: NWCRF Institute, University of Wales, Bangor, LL57 2UW, UK.

{ddagger}{ddagger} To whom correspondence should be addressed: Dept. of Medical Cell Biology, Box 571, Husargatan 3, 75123, Uppsala, Sweden. Tel.: 46-18-4714447; Fax: 46-18-4714059; E-mail: michael.welsh{at}medcellbiol.uu.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
Y. Nakamura, N. Patrushev, H. Inomata, D. Mehta, N. Urao, H. W. Kim, M. Razvi, V. Kini, K. Mahadev, B. J. Goldstein, et al.
Role of Protein Tyrosine Phosphatase 1B in Vascular Endothelial Growth Factor Signaling and Cell-Cell Adhesions in Endothelial Cells
Circ. Res., May 23, 2008; 102(10): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
M. Kowanetz and N. Ferrara
Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. T. Holderfield and C. C.W. Hughes
Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-{beta} in Vascular Morphogenesis
Circ. Res., March 28, 2008; 102(6): 637 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Md. R. Abid, K. C. Spokes, S.-C. Shih, and W. C. Aird
NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways
J. Biol. Chem., November 30, 2007; 282(48): 35373 - 35385.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Bahary, K. Goishi, C. Stuckenholz, G. Weber, J. LeBlanc, C. A. Schafer, S. S. Berman, M. Klagsbrun, and L. I. Zon
Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish
Blood, November 15, 2007; 110(10): 3627 - 3636.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Tian, C.-h. Zhu, X.-w. Zhang, X. Xie, X.-l. Xin, Y.-h. Yi, L.-p. Lin, M.-y. Geng, and J. Ding
Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between Kinase Insert Domain-Containing Receptor (KDR) and {alpha}vbeta3 Integrin via Binding to the Extracellular Domain of KDR
Mol. Pharmacol., September 1, 2007; 72(3): 545 - 552.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. R. Smith, N. H. James, I. Oakley, A. Wainwright, C. Copley, J. Kendrew, L. M. Womersley, J. M. Jurgensmeier, S. R. Wedge, and S. T. Barry
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts
Mol. Cancer Ther., August 1, 2007; 6(8): 2198 - 2208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Garcia Blanes, M. Oubaha, Y. Rautureau, and J.-P. Gratton
Phosphorylation of Tyrosine 801 of Vascular Endothelial Growth Factor Receptor-2 Is Necessary for Akt-dependent Endothelial Nitric-oxide Synthase Activation and Nitric Oxide Release from Endothelial Cells
J. Biol. Chem., April 6, 2007; 282(14): 10660 - 10669.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. J. Singh, R. D. Meyer, G. Navruzbekov, R. Shelke, L. Duan, H. Band, S. E. Leeman, and N. Rahimi
A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLC{gamma}1 activation and angiogenesis
PNAS, March 27, 2007; 104(13): 5413 - 5418.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Zeng, S. M. Taylor, J. R. McColm, N. C. Kappas, J. B. Kearney, L. H. Williams, M. E. Hartnett, and V. L. Bautch
Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation
Blood, February 15, 2007; 109(4): 1345 - 1352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Kriz, N. Agren, C. K. Lindholm, S. Lenell, J. Saldeen, J. Mares, and M. Welsh
The SHB Adapter Protein Is Required for Normal Maturation of Mesoderm during in Vitro Differentiation of Embryonic Stem Cells
J. Biol. Chem., November 10, 2006; 281(45): 34484 - 34491.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Kowanetz and N. Ferrara
Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
Clin. Cancer Res., September 1, 2006; 12(17): 5018 - 5022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dance, A. Montagner, A. Yart, B. Masri, Y. Audigier, B. Perret, J.-P. Salles, and P. Raynal
The Adaptor Protein Gab1 Couples the Stimulation of Vascular Endothelial Growth Factor Receptor-2 to the Activation of Phosphoinositide 3-Kinase
J. Biol. Chem., August 11, 2006; 281(32): 23285 - 23295.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Le Boeuf, F. Houle, M. Sussman, and J. Huot
Phosphorylation of Focal Adhesion Kinase (FAK) on Ser732 Is Induced by Rho-dependent Kinase and Is Essential for Proline-rich Tyrosine Kinase-2-mediated Phosphorylation of FAK on Tyr407 in Response to Vascular Endothelial Growth Factor
Mol. Biol. Cell, August 1, 2006; 17(8): 3508 - 3520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. D. Meyer, X. Qian, H.-C. Guo, and N. Rahimi
Leucine Motif-dependent Tyrosine Autophosphorylation of Type III Receptor Tyrosine Kinases
J. Biol. Chem., March 31, 2006; 281(13): 8620 - 8627.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
O. Kustikova, B. Fehse, U. Modlich, M. Yang, J. Dullmann, K. Kamino, N. von Neuhoff, B. Schlegelberger, Z. Li, and C. Baum
Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking
Science, May 20, 2005; 308(5725): 1171 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Gray, J. S. Wey, A. Belcheva, M. F. McCarty, J. G. Trevino, D. B. Evans, L. M. Ellis, and G. E. Gallick
Neuropilin-1 Suppresses Tumorigenic Properties in a Human Pancreatic Adenocarcinoma Cell Line Lacking Neuropilin-1 Coreceptors
Cancer Res., May 1, 2005; 65(9): 3664 - 3670.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Sakurai, K. Ohgimoto, Y. Kataoka, N. Yoshida, and M. Shibuya
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice
PNAS, January 25, 2005; 102(4): 1076 - 1081.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Le Boeuf, F. Houle, and J. Huot
Regulation of Vascular Endothelial Growth Factor Receptor 2-mediated Phosphorylation of Focal Adhesion Kinase by Heat Shock Protein 90 and Src Kinase Activities
J. Biol. Chem., September 10, 2004; 279(37): 39175 - 39185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.